FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Yuichiro Ohe

Research Profile

Disorders

Chemicals & Drugs

Anatomy

Tumor Cells, Cultured

Procedures

Living Beings

Physiology

Transfection

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Fumiyuki Takahashi; Shigeru Akutagawa; Hisao Fukumoto; Shoji Tsukiyama; Yuichiro Ohe; Kazuhisa Takahashi; Yoshinosuke Fukuchi; Nagahiro Saijo; Kazuto Nishio
Osteopontin induces angiogenesis of murine neuroblastoma cells in mice.
Y Tatsumi; Hitoshi Arioka; S Ikeda; Hisao Fukumoto; K Miyamoto; Kazuya Fukuoka; Yuichiro Ohe; Nagahiro Saijo; Kazuto Nishio
Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6.
Hisao Fukumoto; Kazuto Nishio; S Ohta; N Hanai; Kazuya Fukuoka; Yuichiro Ohe; K Sugihara; T Kodama; Nagahiro Saijo
Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Yuichiro Ohe (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2002: Fumiyuki Takahashi; Shigeru Akutagawa; Hisao Fukumoto; Shoji Tsukiyama; Yuichiro Ohe; Kazuhisa Takahashi; Yoshinosuke Fukuchi; Nagahiro Saijo; Kazuto Nishio
Osteopontin induces angiogenesis of murine neuroblastoma cells in mice.
International journal of cancer. Journal international du cancer 2002;98(5):707-12.
2001: Y Tatsumi; Hitoshi Arioka; S Ikeda; Hisao Fukumoto; K Miyamoto; Kazuya Fukuoka; Yuichiro Ohe; Nagahiro Saijo; Kazuto Nishio
Enhancement of in vivo antitumor activity of a novel antimitotic 1-phenylpropenone derivative, AM-132, by tumor necrosis factor-alpha or interleukin-6.
Japanese journal of cancer research : Gann 2001;92(7):768-77.
1999: Hisao Fukumoto; Kazuto Nishio; S Ohta; N Hanai; Kazuya Fukuoka; Yuichiro Ohe; K Sugihara; T Kodama; Nagahiro Saijo
Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumors in vivo.
International journal of cancer. Journal international du cancer 1999;82(5):759-64.
1997: Yuji Heike; M Takahashi; T Ohira; Ichiro Naruse; Seiji Hama; Yuichiro Ohe; T Kasai; Hisao Fukumoto; K J Olsen; Eckhard R Podack; Nagahiro Saijo
Genetic immunotherapy by intrapleural, intraperitoneal and subcutaneous injection of IL-2 gene-modified Lewis lung carcinoma cells.
International journal of cancer. Journal international du cancer 1997;73(6):844-9.
1997: Hisao Fukumoto; M Nishio; Kazuto Nishio; Yuji Heike; Hitoshi Arioka; Hirokazu Kurokawa; Tomoyuki Ishida; Kazuya Fukuoka; T Nomoto; Yuichiro Ohe; Nagahiro Saijo
Interferon-gamma-inducing factor gene transfection into Lewis lung carcinoma cells reduces tumorigenicity in vivo.
Japanese journal of cancer research : Gann 1997;88(5):501-5.
1996: T Ohira; Kazuto Nishio; Fumihiko Kanzawa; Tomoyuki Ishida; Yuichiro Ohe; Hitoshi Arioka; Y Funayama; H Ogasawara; H Kato; Nagahiro Saijo
Hypersensitivity of NIH3T3 cells transformed by H-ras gene to DNA-topoisomerase-I inhibitors.
International journal of cancer. Journal international du cancer 1996;67(5):702-8.
1996: N Katsumata; K Eguchi; M Fukuda; N Yamamoto; Yuichiro Ohe; F Oshita; T Tamura; T Shinkai; Nagahiro Saijo
Serum levels of cytokines in patients with untreated primary lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):553-9.
1996: T Ohira; Kazuto Nishio; Yuichiro Ohe; Hitoshi Arioka; M Nishio; Y Funayama; H Ogasawara; M Fukuda; K Yazawa; H Kato; Nagahiro Saijo
Improvement by eicosanoids in cancer cachexia induced by LLC-IL6 transplantation.
Journal of cancer research and clinical oncology 1996;122(12):711-5.
1996: Nagahiro Saijo; Kazuto Nishio; S Ohta; Hitoshi Arioka; Y Funayama; Kazuya Fukuoka; H Kurokawa; T Nomoto; Tomoyuki Ishida; N Yamamoto; T Tamura; T Shinkai; K Eguchi; Yuichiro Ohe; H Kunito; T Ohtsu; Yasutsuna Sasaki
Progress in preclinical and clinical studies for the development of new anticancer drugs in Japan, with emphasis on taxanes.
Cancer chemotherapy and pharmacology 1996;38 Suppl():S11-5.
1995: F Oshita; T Kurata; T Kasai; M Fakuda; N Yamamoto; Yuichiro Ohe; T Tamura; K Eguchi; T Shinkai; Nagahiro Saijo
Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions.
Japanese journal of cancer research : Gann 1995;86(12):1198-202.
1995: F Oshita; N Yamamoto; M Fukuda; Yuichiro Ohe; T Tamura; K Eguchi; T Shinkai; Nagahiro Saijo
Correlation of therapeutic outcome in non-small cell lung cancer and DNA damage assayed by polymerase chain reaction in leukocytes damaged in vitro.
Cancer research 1995;55(11):2334-7.
1995: M Fukuda; Yuichiro Ohe; F Kanzawa; M Oka; K Hara; Nagahiro Saijo
Evaluation of novel platinum complexes, inhibitors of topoisomerase I and II in non-small cell lung cancer (NSCLC) sublines resistant to cisplatin.
Anticancer research 1995;15(2):393-8.
1995: N Yamamoto; T Tamura; M Maeda; M Ando; T Shinkai; K Eguchi; Yuichiro Ohe; F Oshita; J Shiraishi; N Katsumata
The influence of ageing on cisplatin pharmacokinetics in lung cancer patients with normal organ function.
Cancer chemotherapy and pharmacology 1995;36(2):102-6.
1994: H Ohmatsu; K Eguchi; T Shinkai; T Tamura; Yuichiro Ohe; M Nisio; H Kunikane; Hitoshi Arioka; A Karato; H Nakashima
A randomized cross-over study of high-dose metoclopramide plus dexamethasone versus granisetron plus dexamethasone in patients receiving chemotherapy with high-dose cisplatin.
Japanese journal of cancer research : Gann 1994;85(11):1151-8.
1994: T Tamura; Yasutsuna Sasaki; K Eguchi; T Shinkai; Yuichiro Ohe; M Nishio; H Kunikane; Hitoshi Arioka; A Karato; H Omatsu
Phase I and pharmacokinetic study of paclitaxel by 24-hour intravenous infusion.
Japanese journal of cancer research : Gann 1994;85(10):1057-62.
1994: H Koga; K Eguchi; T Shinkai; T Tamura; Yuichiro Ohe; F Oshita; Nagahiro Saijo; H Kondo; K Oki; H Okura
Preliminary evaluation of the new tumor marker, CYFRA 21-1, in lung cancer patients.
Japanese journal of clinical oncology 1994;24(5):263-8.
1994: N Yamamoto; T Tamura; A Karato; K Uenaka; K Eguchi; T Shinkai; Yuichiro Ohe; F Oshita; Hitoshi Arioka; H Nakashima
CPT-11: population pharmacokinetic model and estimation of pharmacokinetics using the Bayesian method in patients with lung cancer.
Japanese journal of cancer research : Gann 1994;85(9):972-7.
1994: T Ohira; Yuichiro Ohe; Yuji Heike; Eckhard R Podack; K J Olsen; Kazuto Nishio; M Nishio; Y Miyahara; Y Funayama; H Ogasawara
Gene therapy for Lewis lung carcinoma with tumor necrosis factor and interleukin 2 cDNAs co-transfected subline.
Gene therapy 1994;1(4):269-75.
1994: T Shinkai; Hitoshi Arioka; H Kunikane; K Eguchi; Yasutsuna Sasaki; T Tamura; Yuichiro Ohe; F Oshita; M Nishio; A Karato
Phase I clinical trial of irinotecan (CPT-11), 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxy-camptothecin, and cisplatin in combination with fixed dose of vindesine in advanced non-small cell lung cancer.
Cancer research 1994;54(10):2636-42.
1994: Nagahiro Saijo; Kazuto Nishio; N Kubota; Fumihiko Kanzawa; T Shinkai; A Karato; Yasutsuna Sasaki; K Eguchi; T Tamura; Yuichiro Ohe
7-Ethyl-10-[4-(1-piperidino)-1-piperidino] carbonyloxy camptothecin: mechanism of resistance and clinical trials.
Cancer chemotherapy and pharmacology 1994;34 Suppl():S112-7.
1994: T Ohira; Yuichiro Ohe; Yuji Heike; Eckhard R Podack; K J Olsen; Kazuto Nishio; M Nishio; Y Miyahara; Y Funayama; H Ogasawara
In vitro and in vivo growth of B16F10 melanoma cells transfected with interleukin-4 cDNA and gene therapy with the transfectant.
Journal of cancer research and clinical oncology 1994;120(11):631-5.
1994: K Eguchi; H Etou; S Miyachi; H Morinari; K Nakada; K Noda; Y Ohkuni; K Watanabe; Y Yamada; Yuichiro Ohe
A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(2):188-94.
1993: A Karato; Yasutsuna Sasaki; T Shinkai; K Eguchi; T Tamura; Yuichiro Ohe; F Oshita; M Nishio; H Kunikane; Hitoshi Arioka
Phase I study of CPT-11 and etoposide in patients with refractory solid tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(10):2030-5.
1993: Yuichiro Ohe; Eckhard R Podack; K J Olsen; Y Miyahara; K Miura; H Saito; Y Koishihara; Y Ohsugi; T Ohira; Kazuto Nishio
Interleukin-6 cDNA transfected Lewis lung carcinoma cells show unaltered net tumour growth rate but cause weight loss and shortened survival in syngeneic mice.
British journal of cancer 1993;67(5):939-44.
1993: Yuichiro Ohe; Eckhard R Podack; K J Olsen; Y Miyahara; T Ohira; K Miura; Kazuto Nishio; Nagahiro Saijo
Combination effect of vaccination with IL2 and IL4 cDNA transfected cells on the induction of a therapeutic immune response against Lewis lung carcinoma cells.
International journal of cancer. Journal international du cancer 1993;53(3):432-7.
1992: T Ohira; Yuichiro Ohe; Nagahiro Saijo
[Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma].
Nihon Kyōbu Shikkan Gakkai zasshi 1992;30 Suppl():48-51.
1992: H Okamoto; Nagahiro Saijo; T Shinkai; K Eguchi; Yasutsuna Sasaki; T Tamura; Yuichiro Ohe; A Kojima; H Kunikane; A Karato
Chemotherapy-induced anemia in patients with primary lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(10):819-24.
1992: Yuichiro Ohe; Yasutsuna Sasaki; T Shinkai; K Eguchi; T Tamura; A Kojima; H Kunikane; H Okamoto; A Karato; H Ohmatsu
Phase I study and pharmacokinetics of CPT-11 with 5-day continuous infusion.
Journal of the National Cancer Institute 1992;84(12):972-4.
1992: Y Sugimoto; Yuichiro Ohe; Kazuto Nishio; T Ohmori; T Morikage; Y Fujiwara; Nagahiro Saijo
Mechanisms of collateral sensitivity to fluorouracil of a cis-diamminedichloroplatinum(II)-resistant human non-small lung cancer cell line.
British journal of cancer 1992;65(6):857-64.
1992: Y Sugimoto; Yuichiro Ohe; Kazuto Nishio; T Ohmori; Y Fujiwara; Nagahiro Saijo
In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.
Cancer chemotherapy and pharmacology 1992;30(6):417-22.
1992: T Shinkai; K Eguchi; Yasutsuna Sasaki; T Tamura; Yuichiro Ohe; A Kojima; F Oshita; T Miya; H Okamoto; K Iemura
A prognostic-factor risk index in advanced non-small-cell lung cancer treated with cisplatin-containing combination chemotherapy.
Cancer chemotherapy and pharmacology 1992;30(1):1-6.
1991: F Oshita; T Tamura; H Okamoto; T Miya; A Kojima; Yuichiro Ohe; Yasutsuna Sasaki; K Eguchi; T Shinkai; Nagahiro Saijo
The frequency and management of infectious episodes and sepsis in small cell lung cancer patients receiving intensive chemotherapy with granulocyte-colony stimulating factor.
Japanese journal of clinical oncology 1991;21(5):353-9.
1991: A Kojima; T Shinkai; K Eguchi; Yasutsuna Sasaki; T Tamura; Yuichiro Ohe; F Oshita; T Miya; H Okamoto; H Kondo
Analysis of three-year survivors among patients with advanced inoperable non-small cell lung cancer.
Japanese journal of clinical oncology 1991;21(4):276-81.
1991: Yasutsuna Sasaki; T Amano; M Morita; T Shinkai; K Eguchi; T Tamura; Yuichiro Ohe; A Kojima; Nagahiro Saijo
Phase I study and pharmacological analysis of cis-diammine(glycolato)platinum (254-S; NSC 375101D) administered by 5-day continuous intravenous infusion.
Cancer research 1991;51(5):1472-7.
1991: F Oshita; T Shinkai; T Miya; A Kojima; Yuichiro Ohe; T Tamura; Yasutsuna Sasaki; K Eguchi; Nagahiro Saijo
[The relation between myelotoxicity and performance status or aging in chemotherapy of non-small cell lung cancer].
Nihon Kyōbu Shikkan Gakkai zasshi 1991;29(2):231-8.
1991: K Yamada; Nagahiro Saijo; A Kojima; Yuichiro Ohe; T Tamura; Yasutsuna Sasaki; K Eguchi; T Shinkai; T Goya; H Kondou
A retrospective analysis of patients receiving surgery after chemotherapy for small cell lung cancer.
Japanese journal of clinical oncology 1991;21(1):39-45.
1991: F Oshita; T Tamura; A Kojima; K Yamada; M Fukuda; K Nakagawa; Yuichiro Ohe; Yasutsuna Sasaki; K Eguchi; T Shinkai
Late toxicities and complications in three-year survivors of small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(4):427-30.
1991: Yasutsuna Sasaki; T Shinkai; K Eguchi; T Tamura; Yuichiro Ohe; T Ohmori; Nagahiro Saijo
Prediction of the antitumor activity of new platinum analogs based on their ex vivo pharmacodynamics as determined by bioassay.
Cancer chemotherapy and pharmacology 1991;27(4):263-70.
1991: T Shinkai; K Eguchi; Yasutsuna Sasaki; T Tamura; Yuichiro Ohe; A Kojima; F Oshita; Nagahiro Saijo
A randomised clinical trial of vindesine plus cisplatin versus mitomycin plus vindesine and cisplatin in advanced non-small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1991;27(5):571-5.
1990: Yuichiro Ohe; T Shinkai; K Eguchi; Yasutsuna Sasaki; T Tamura; K Nakagawa; A Kojima; K Yamada; F Oshita; T Miya
Negative phase II study of 5-fluorouracil with high-dose leucovorin in non-small cell lung cancer.
Japanese journal of clinical oncology 1990;20(4):364-8.
1990: M Bungo; Y Fujiwara; K Kasahara; K Nakagawa; Yuichiro Ohe; Yasutsuna Sasaki; S Irino; Nagahiro Saijo
Decreased accumulation as a mechanism of resistance to cis-diamminedichloroplatinum(II) in human non-small cell lung cancer cell lines: relation to DNA damage and repair.
Cancer research 1990;50(9):2549-53.
1990: Yasutsuna Sasaki; M Fukuda; M Morita; T Shinkai; K Eguchi; T Tamura; Yuichiro Ohe; K Yamada; A Kojima; K Nakagawa
Prediction from creatinine clearance of thrombocytopenia and recommended dose in patients receiving (glycolato-O,O')-diammine platinum (II) (NSC 375101D).
Japanese journal of cancer research : Gann 1990;81(2):196-200.
1990: M Fukuda; T Shinkai; K Eguchi; Yasutsuna Sasaki; T Tamura; Yuichiro Ohe; A Kojima; F Oshita; K Hara; Nagahiro Saijo
Phase II study of (glycolate-O,O') diammineplatinum(II), a novel platinum complex, in the treatment of non-small-cell lung cancer.
Cancer chemotherapy and pharmacology 1990;26(6):393-6.
1990: M Sakurai; M Iigo; Yasutsuna Sasaki; K Nakagawa; Y Fujiwara; T Tamura; Yuichiro Ohe; M Bungo; Nagahiro Saijo
Lack of correlation between interferon levels induced by polyribonucleotides and their antimetastatic effect.
Oncology 1990;47(3):251-6.
1989: Yuichiro Ohe; K Nakagawa; Y Fujiwara; Yasutsuna Sasaki; K Minato; M Bungo; S Niimi; N Horichi; M Fukuda; Nagahiro Saijo
In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.
Cancer research 1989;49(15):4098-102.
1989: T Shinkai; Nagahiro Saijo; K Eguchi; Yasutsuna Sasaki; T Tamura; Y Fujiwara; M Mae; M Fukuda; Yuichiro Ohe; S Sasaki
Control of cisplatin-induced delayed emesis with metoclopramide and dexamethasone: a randomized controlled trial.
Japanese journal of clinical oncology 1989;19(1):40-4.
1989: Y Ohsaki; Yuichiro Ohe; S Niimi; K Nakagawa; K Minato; M Bungo; Yasutsuna Sasaki; N Horichi; K Eguchi; Nagahiro Saijo
[Effects of recombinant human colony stimulating factor (rh-CSFs) on colony formation of lung cancer cell lines].
Gan to kagaku ryoho. Cancer & chemotherapy 1989;16(3 Pt 1):431-3.
1989: T Tamura; T Shinkai; K Eguchi; Yasutsuna Sasaki; Y Fujiwara; M Fukuda; Yuichiro Ohe; K Nakagawa; K Minato; Nagahiro Saijo
Phase II study of carboplatin in non-small cell lung cancer.
Japanese journal of clinical oncology 1989;19(1):51-5.
1989: Atsushi Ohtsu; Yasutsuna Sasaki; T Tamura; Y Fujiwara; Yuichiro Ohe; K Minato; K Nakagawa; M Bungo; Nagahiro Saijo
Inhibition of colony formation of drug-resistant human tumor cell lines by combinations of interleukin-2-activated killer cells and antitumor drugs.
Japanese journal of cancer research : Gann 1989;80(3):265-70.
1989: Yasutsuna Sasaki; T Tamura; K Eguchi; T Shinkai; Y Fujiwara; M Fukuda; Yuichiro Ohe; M Bungo; N Horichi; S Niimi
Pharmacokinetics of (glycolate-0,0')-diammine platinum (II), a new platinum derivative, in comparison with cisplatin and carboplatin.
Cancer chemotherapy and pharmacology 1989;23(4):243-6.
1988: M Sakurai; M Iigo; T Tamura; A Otsu; Yasutsuna Sasaki; H Nakano; K Nakagawa; K Minato; Yuichiro Ohe; Nagahiro Saijo
Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanoma.
Cancer immunology, immunotherapy : CII 1988;26(2):109-13.
1988: N Horiuchi; K Nakagawa; Yasutsuna Sasaki; K Minato; Y Fujiwara; K Nezu; Yuichiro Ohe; Nagahiro Saijo
In vitro antitumor activity of mitomycin C derivative (RM-49) and new anticancer antibiotics (FK973) against lung cancer cell lines determined by tetrazolium dye (MTT) assay.
Cancer chemotherapy and pharmacology 1988;22(3):246-50.